Vimarsana
Biggest News Aggregation in the World

Page 46 - Service Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Service Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Service Testing Today - Breaking & Trending Today

NetScientific Announces Preliminary Biomarker Study Results for Head, Neck Cancer - Vimarsana News

NetScientific Announces Preliminary Biomarker Study Results for Head, Neck Cancer

By Anthony O. Goriainoff NetScientific said that its portfolio company PDS Biotechnology announced data from the phase 2 clinical trial evaluating the safety...

Black Market for Weight Loss Drug Retatrutide Spreads Online Years Ahead of FDA Approvals - Vimarsana News

Black Market for Weight Loss Drug Retatrutide Spreads Online Years Ahead of FDA Approvals

Eli Lilly’s retatrutide will be in clinical trials for the next three years, but knockoff versions already abound

Source: wsj.com
Evelo Biosciences Reviewing Alternatives After Study Didn't Meet Endpoint - Vimarsana News

Evelo Biosciences Reviewing Alternatives After Study Didn't Meet Endpoint

By Will Feuer Evelo Biosciences said it is reviewing strategic alternatives after its Phase 2 clinical trial of EDP2939 for the treatment of moderate...

Evelo Biosciences Shares Down 58% After Unfavorable EDP2939 Results - Vimarsana News

Evelo Biosciences Shares Down 58% After Unfavorable EDP2939 Results

By Josh Beckerman Evelo Biosciences shares fell 58% as the company said it will discontinue EDP2939 after a Phase 2 study in moderate psoriasis didn't meet...

Omeros to Discontinue Narsoplimab Trial After Early Data Didn't Meet Primary Endpoint - Vimarsana News

Omeros to Discontinue Narsoplimab Trial After Early Data Didn't Meet Primary Endpoint

By Will Feuer Omeros said it is discontinuing its late-stage clinical trial evaluating its narsoplimab drug for the treatment of immunoglobulin A nephropathy...